Literature DB >> 16369752

Successful diagnosis of thromboembolism before surgery in a woman with clear cell adenocarcinoma of the endometrium.

Maki Toyoda1, Toyomi Satoh, Katsumi Takano, Nakako Okada Sato, Akinori Oki, Hajime Tsunoda, Hiroyuki Yoshikawa.   

Abstract

Patients with ovarian cancer with clear cell histology often have venous thromboembolism (VTE) even before surgery. In view of the possible association between clear cell histology and VTE in endometrial cancer, we measured the plasma levels of thrombin-antithrombin III complex (TAT) and D-dimer (DD) in the preoperative examinations of a patient with clear cell adenocarcinoma of the endometrium. Plasma TAT and DD were both highly elevated, though the patient had no symptoms of VTE or risk factors such as obesity or diabetes mellitus. Ultrasound Doppler examination and lung perfusion scintigraphy just before surgery revealed a thrombosis in the left popliteal vein and a pulmonary embolism. After implanting an inferior vena cava filter to prevent a fatal embolism of the lung, we performed abdominal total hysterectomy, bilateral salpingo-oophorectomy, and sampling of the pelvic lymph nodes. The VTE gradually disappeared and the plasma levels of TAT and DD returned to normal after surgery. Possibly, the VTE in this patient may have been associated with the clear cell histology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16369752     DOI: 10.1007/s10147-005-0517-6

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.850


  6 in total

1.  Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract.

Authors:  R Vang; B P Whitaker; A I Farhood; E G Silva; J Y Ro; M T Deavers
Journal:  Int J Gynecol Pathol       Date:  2001-07       Impact factor: 2.762

2.  Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients.

Authors:  F Turkstra; E J van Beek; J W ten Cate; H R Büller
Journal:  Thromb Haemost       Date:  1996-07       Impact factor: 5.249

3.  Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease.

Authors:  B A Goff; R Sainz de la Cuesta; H G Muntz; D Fleischhacker; M Ek; L W Rice; N Nikrui; H K Tamimi; J M Cain; B E Greer; A F Fuller
Journal:  Gynecol Oncol       Date:  1996-03       Impact factor: 5.482

4.  Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy.

Authors:  F O Recio; M S Piver; R E Hempling; D L Driscoll
Journal:  Cancer       Date:  1996-11-15       Impact factor: 6.860

5.  Diagnostic value of plasma thrombin-antithrombin III complex and D-dimer concentration in patients with varicose veins for exclusion of deep-vein thrombosis.

Authors:  T Kawasaki; N Shinoki; S Iwamoto; H Fujimura; N Yoshikawa; Y Ohta; M Ikeda; H Ariyoshi; T Shibuya; M Monden
Journal:  Thromb Res       Date:  1998-07-15       Impact factor: 3.944

Review 6.  Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview.

Authors:  H Bounameaux; P de Moerloose; A Perrier; G Reber
Journal:  Thromb Haemost       Date:  1994-01       Impact factor: 5.249

  6 in total
  2 in total

1.  Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer.

Authors:  Jianpei Li; Jianhua Lin; Yaoling Luo; Miaohuan Kuang; Yijun Liu
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

2.  Silent venous thromboembolism before treatment in endometrial cancer and the risk factors.

Authors:  T Satoh; K Matsumoto; K Uno; M Sakurai; S Okada; M Onuki; T Minaguchi; Y O Tanaka; S Homma; A Oki; H Yoshikawa
Journal:  Br J Cancer       Date:  2008-09-09       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.